Barry P. Flannelly Pharm.D., MBA — Executive VP & General Manager of U.S. at Incyte Corporation

Dr. Barry P. Flannelly, Pharm.D., MBA has been an Executive Vice President and General Manager of US at Incyte Corporation since June 19, 2015. Dr. Flannelly served as Executive Vice President of Business Development and Strategic Planning at Incyte Corporation from August 2014 to June 2015. Dr. Flannelly served as the Senior Vice President of Commercial at Onyx Pharmaceuticals, Inc. since August 2010. Dr. Flannelly served as Senior Vice President of Global and Strategic Marketing at Onyx Pharmaceuticals, Inc. since October 2008 until August 2010. Dr. Flannelly served as Vice President of Global Sales and Marketing of ABI Division at Fresenius Kabi Pharmaceuticals Holding, Inc. (formerly APP Pharmaceuticals, Inc., Abraxis Bioscience, Inc) since January 2006. Dr. Flannelly served as Vice President of Global Commercial Operations at Abraxis Oncology. Dr. Flannelly was responsible for Global Product Strategy for Novartis Oncology's breast cancer franchise. He served as Global Brand Leader of global marketing of Novartis Oncology, where he was responsible for the worldwide brand strategy for Femara from January 2005 to January 2006. From September 1997 to January 2005, Dr. Flannelly served at Rhone-Poulenc Rohrer and Aventis and Vice President of Oncology Marketing at Sanofi-Aventis, where he oversaw the sales and marketing strategy for Taxotere ?? , Anzemet ?? and Elitek ??. From January 1984 to July 1997, he was a practicing Pharmacist and managed pharmacy services for the John Hopkins Oncology center in Baltimore, Maryland. Dr. Flannelly received a Doctor of Pharmacy degree from the University of Maryland, an M.B.A. from the University of Baltimore and a B.S. in Pharmacy from the Massachusetts College of Pharmacy.